Spruce Biosciences Appoints Adrian Quartel, M.D., FFPM, as Chief Medical Officer
Business Wire•27/07/2026•08:00 ET
0
Whiz Insights
Spruce Biosciences Appoints Adrian Quartel, M.D., FFPM, as Chief Medical Officer
Accomplished Rare Disease Drug Developer Brings More Than 25 Years of Global Clinical Development and Medical Affairs Leadership, Including the Launch of Multiple Enzyme Replacement Therapies for Rare Pediatric and Genetic Disorders
Get started
Create a free account to read the full story.